---

Risk Factors:

Pregnancy/Lactation: Distributed in breast milk. Children: Safety and efficacy not esTabletlished in children younger than 4 yrs of age. Elderly: Age-related renal impairment may require dosage adjustment.Contraindications: Hypersensitivity to terbinafine. Chronic or active hepatic disease.

---

Indications:

Systemic: Treatment of onychomycosis (fungal disease of nails due to
dermatophytes). Treatment of tinea Capsolitis. Topical: Treatment of tinea cruris
(jock itch) tinea pedis (athlete?s foot) tinea corporis (ringworm) tinea
versicolor.

---

Adverse Effects:

Frequent (13%): PO: Headache. Occasional (6%?3%): PO: Abdominal pain
flatulence urticaria visual disturbance. Rare: PO: Diarrhea rash dyspepsia
pruritus altered taste nausea. Topical: Irritation burning pruritus dryness.
Adverse effects/toxic reactions
Hepatobiliary dysfunction (including cholestatic hepatitis) serious skin
reactions severe neutropenia occur rarely. Ocular lens retinal changes have been
noted.

---